Christopher Durant Turner - Net Worth and Insider Trading
Christopher Durant Turner Net Worth
The estimated net worth of Christopher Durant Turner is at least $1 Million dollars as of 2024-11-13. Christopher Durant Turner is the Chief Medical Officer of Nuvalent Inc and owns about 14,513 shares of Nuvalent Inc (NUVL) stock worth over $1 Million. Details can be seen in Christopher Durant Turner's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Christopher Durant Turner has not made any transactions after 2023-10-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Christopher Durant Turner
Christopher Durant Turner Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Christopher Durant Turner owns 1 companies in total, including Nuvalent Inc (NUVL) .
Click here to see the complete history of Christopher Durant Turner’s form 4 insider trades.
Insider Ownership Summary of Christopher Durant Turner
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NUVL | Nuvalent Inc | 2023-10-04 | Chief Medical Officer |
Christopher Durant Turner Latest Holdings Summary
Christopher Durant Turner currently owns a total of 1 stock. Christopher Durant Turner owns 14,513 shares of Nuvalent Inc (NUVL) as of October 4, 2023, with a value of $1 Million.
Latest Holdings of Christopher Durant Turner
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NUVL | Nuvalent Inc | 2023-10-04 | 14,513 | 90.29 | 1,310,379 |
Holding Weightings of Christopher Durant Turner
Christopher Durant Turner Form 4 Trading Tracker
According to the SEC Form 4 filings, Christopher Durant Turner has made a total of 4 transactions in Nuvalent Inc (NUVL) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Nuvalent Inc is the sale of 7,995 shares on October 4, 2023, which brought Christopher Durant Turner around $432,050.
Insider Trading History of Christopher Durant Turner
- 1
Christopher Durant Turner Trading Performance
Christopher Durant Turner Ownership Network
Ownership Network List of Christopher Durant Turner
Ownership Network Relation of Christopher Durant Turner
Christopher Durant Turner Owned Company Details
What does Nuvalent Inc do?
Who are the key executives at Nuvalent Inc?
Christopher Durant Turner is the Chief Medical Officer of Nuvalent Inc. Other key executives at Nuvalent Inc include See Remarks Darlene Noci , Chief Financial Officer Alexandra Balcom , and director & 10 percent owner & other: Director by Deputization James E Flynn .
Nuvalent Inc (NUVL) Insider Trades Summary
Over the past 18 months, Christopher Durant Turner made 4 insider transaction in Nuvalent Inc (NUVL) with a net sale of 23,560. Other recent insider transactions involving Nuvalent Inc (NUVL) include a net sale of 536,000 shares made by Matthew Shair , a net sale of 143,000 shares made by Darlene Noci , and a net sale of 124,546 shares made by Deborah Ann Miller .
In summary, during the past 3 months, insiders sold 2,146,629 shares of Nuvalent Inc (NUVL) in total and bought 0 shares, with a net sale of 2,146,629 shares. During the past 18 months, 3,924,068 shares of Nuvalent Inc (NUVL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 3,924,068 shares.
Nuvalent Inc (NUVL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Nuvalent Inc Insider Transactions
Christopher Durant Turner Mailing Address
Above is the net worth, insider trading, and ownership report for Christopher Durant Turner. You might contact Christopher Durant Turner via mailing address: One Broadway, 14th Floor, Cambridge Ma 02142.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
